Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study-Reference-Cited by-同舟云学术

Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study

Published:2023-06 Issue:3 Volume:8 Page:101574
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Alouani E.,Mercier M.,Flecchia C.,Auclin E.,Hollebecque A.,Mazard T.,Turpin A.,Pernot S.,Cohen R.,Dutherage M.,Kim S.,Sclafani F.,Ben-Abdelghani M.,Herve C.,Aparicio T.,De La Fouchardière C.,Perkins G.,Hautefeuille V.,Jaffrelot M.,Gallois C.,Bongard V.,Tougeron D.,Taïeb J.,Guimbaud R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Mis-match repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies;Venderbosch;Clin Cancer Res,2014

2. Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: an AGEO retrospective multicenter study;Tougeron;Int J Cancer,2020

3. Pembrolizumab in microsatellite-instability–high advanced colorectal cancer;André;N Engl J Med,2020

4. PD-1 blockade in tumors with mismatch-repair deficiency;Le;N Engl J Med,2015

5. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade;Le;Science,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and challenges of anti-PD1 in MSI-H mCRC: a case report on concurrent infections and ir-AIHA;Frontiers in Oncology;2024-08-13

2. T-cell responses in colorectal peritoneal metastases are recapitulated in a humanized immune system mouse model;Frontiers in Immunology;2024-07-09

3. Immune checkpoint inhibitors in colorectal cancer: limitation and challenges;Frontiers in Immunology;2024-06-11

4. Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/ mismatch repair-deficient solid tumors;CHINESE J CANCER RES;2024

5. Tumor Budding, p53, and DNA Mismatch Repair Markers in Sinonasal Intestinal-Type Adenocarcinoma: A Retrospective Study Supports the Adverse Prognostic Impact of Tumor Budding;Cancers;2024-05-16